Scopia Capital Management 13F holdings, Q2 2020
Holdings as of June 30, 2020 · filings on SEC EDGAR · latest filing →
Scopia Capital Management disclosed 20 US equity positions worth $893.5m in its Q2 2020 13F filing. The largest position was S9Q at 16.1% of the reported book, followed by EQUITRANS MIDSTREAM CORP and BABA. Against the Q1 2020 filing, it opened 6 new positions, added to 4 and reduced 10 among the top 20 holdings.
What did Scopia Capital Management own in Q2 2020? Top 20 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs Q1 2020 |
|---|---|---|---|---|---|---|---|
| 1 | S9Q SPIRIT AEROSYSTEMS HLDGS INC | 16.1% | $144.0m | 6,015,600 | 35% | added | |
| 2 | EQUITRANS MIDSTREAM CORP | 14.3% | $127.6m | 15,356,584 | 33% | added | |
| 3 | BABA ALIBABA GROUP HLDG LTD | Consumer Cyclical | 13.3% | $118.6m | 549,958 | -26% | reduced |
| 4 | JCI JOHNSON CTLS INTL PLC | Industrials | 9.8% | $87.6m | 2,565,972 | -3% | reduced |
| 5 | VST VISTRA ENERGY CORP | Utilities | 7.4% | $65.9m | 3,538,827 | -57% | reduced |
| 6 | KBR KBR INC | Industrials | 5.7% | $50.9m | 2,259,335 | – | new |
| 7 | CNMD CONMED CORP | Healthcare | 5.2% | $46.6m | 647,195 | – | new |
| 8 | HLIT HARMONIC INC | Technology | 4.9% | $43.9m | 9,242,115 | 49% | added |
| 9 | RETROPHIN INC | 4.1% | $36.5m | 1,785,909 | 3% | added | |
| 10 | VRRM VERRA MOBILITY CORP | Technology | 3.5% | $31.3m | 3,040,360 | – | new |
| 11 | GDOT GREEN DOT CORP | Financial Services | 3.5% | $30.8m | 628,411 | -63% | reduced |
| 12 | ITRI ITRON INC | Technology | 3.1% | $27.9m | 420,572 | -58% | reduced |
| 13 | HORIZON THERAPEUTICS PUB LTD | 2.9% | $26.3m | 473,575 | -63% | reduced | |
| 14 | MPC MARATHON PETE CORP | Energy | 2.3% | $20.6m | 550,359 | – | new |
| 15 | NRG NRG ENERGY INC | Utilities | 1.9% | $17.1m | 523,804 | -37% | reduced |
| 16 | CC CHEMOURS CO | Basic Materials | 1.3% | $11.5m | 746,262 | -14% | reduced |
| 17 | BARCLAYS BK PLC | 0.5% | $4.1m | 121,653 | – | new | |
| 18 | MNKD MANNKIND CORP | Healthcare | 0.1% | $1.2m | 694,961 | – | new |
| 19 | PORTOLA PHARMACEUTICALS INC | 0.1% | $755.0k | 41,945 | -31% | reduced | |
| 20 | TG7 TRIUMPH GROUP INC NEW | 0.0% | $421.0k | 46,766 | -31% | reduced |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.